Stanford University
Showing 121-130 of 192 Results
-
Antonios Chronopoulos
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors
-
Alvina Dor-Yan Chu
Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioAlex Weihan Chu, M.D. is a Clinical Assistant Professor at Stanford University School of Medicine and Associate Chief Medical Officer and Vice President for Clinical Affairs, Quality, and Health Equity at Stanford Health Care – Tri-Valley.
Dr. Chu joined Tri-Valley as an academic hospitalist in 2015 after completing his internal medicine residency at Stanford. He served as a Clinical Instructor from 2015 to 2018 and has been a Clinical Assistant Professor since 2018. He is board-certified in Internal Medicine and Clinical Informatics and has served as Tri-Valley’s Medical Informatics Director since 2016.
In his current executive role, which began in 2024, Dr. Chu provides clinical leadership for medical staff quality, patient safety, and performance improvement. He chairs the Joint Quality Council, co-leads Unit-Based Medical Director engagement, and leads strategic work in employee engagement and physician wellness, community partnerships and health equity, and digital innovation. His responsibilities also include clinical affairs, specialty coverage planning, physician agreements, and directorships. In 2026, he became executive sponsor for Support Services II (Telecom, TDS, and BioMed) in the Highly Reliable Patient Centered Care management system launch.
Dr. Chu previously served as Associate Chief Medical Officer for Patient Safety, Infection Control, and Regulatory Compliance (2022–2024) and Vice Chief of Medicine (2021–2023). His work spans accreditation readiness, clinical documentation, transfusion safety, physician engagement, and clinical workflow redesign. He founded the Clinician Builder Program in 2019 and the Health Information Management Services Committee in 2020. His projects include telemedicine services, digital procedure consents, clinical decision support, order set optimization, and support for the Tri-Valley neurosurgery program launch planned for December 2026.
Dr. Chu is a reviewer for Applied Clinical Informatics and received the Division of Hospital Medicine’s Excellence in Interprofessional Practice Award in 2025. His professional development includes the Stanford Leadership Development Program (2024) and the Just Culture Conduct Course for Healthcare Managers & Influencers offered by The Just Culture Company (2026).
Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring advancements in technology. -
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
